Concepedia

Publication | Open Access

Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease

DOIFull Paper Access

44

Citations

29

References

2007

Year

GM Pastores, Erin Boyd, Keith A. Crandall, Alison J. Whelan, Linda Piersall, Nicole E. Barnett
Nephrology Dialysis Transplantation

Abstract

The same dosing regimen of agalsidase alfa may be safely administered to FD patients with ESRD as given to those without ESRD.

References

YearCitations

Page 1